10.1038/s41598-020-75621-5 Summary Keywords incretinbased therapy, GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), T2D (type 2 diabetes), obesity, incretin receptors Citation Austin GO and Tomas A (2023) Variation in responses to incretin therapy: Modifiable and non-modifiable factors
It transports long-chain fatty acids into the mitochondria so they can be oxidized (burned) to produce energy
While this mechanism is highly effective for weight management and diabetes control, it creates a cascade of effects throughout your digestive system that can significantly impact your gut microbiome and overall digestive health
For Hashimoto's patients who prefer oral therapy or wish to explore dual-compound options, PlexusDx also offers oral semaglutide at $289/mo month-to-month, or from $249/mo on the 6-month plan and GLP-Squared injection (semaglutide plus tirzepatide) $289/mo month-to-month, or from $249/mo on the 6-month plan
Geographic Availability Available in all 50 states (eligibility for compounded meds varies by state) Oral kits restricted in some states Clinical Oversight and Safety Licensed clinicians oversee prescriptions based on form submission
Schweiger V, Villagrossi L, Taus F, et al